Looking to sell Asimov stock or options?Contact us
Asimov, a developer of mammalian cell engineering software, aims to expedite the creation and production of gene therapies and biologics. The firm's platform unifies synthetic biology, machine learning-based design, and biophysical simulations to engineer genetic circuits in biotechnology. This allows healthcare institutions to streamline the design and printing of genetic logic gates, leading to the development of sophisticated therapeutics and manufacturing applications.
Fidelity Investments, Casdin Capital, Wing Venture Capital, Pillar VC, Frog Design, Horizons Ventures, AME Cloud Ventures, CPP Investments, KdT Ventures, DCVC.
We have an even better solution: The Collective Exchange Fund
Get in touch and see if we can help you